Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2005
12/28/2005CN1233234C (S)-Enantiomer enriched tipronil composition
12/27/2005US6979750 Drug treating positive inotropic on the heart without affecting the heart rate, lowing body temperature, diseases caused by G protein coupled receptor, like congestive heart failure, bipolar disorder, depression, schizophrenia, eating disorders
12/27/2005US6979747 Antioxidants, preparation processes and their uses
12/27/2005US6979741 Acetyl-CoA carboxylase inhibitors
12/27/2005US6979738 Quadruplex stabilizer
12/27/2005US6979735 Agglomerates by crystallization
12/27/2005US6979730 Nucleic acids encoding prostate stem cell antigen
12/27/2005US6979698 Method of treating cognitive deficits in learning and memory
12/27/2005US6979697 Regulation of substrate activity
12/27/2005US6979695 Compounds capable of activating cholinergic receptors
12/27/2005US6979694 Drugs such as (5-(((2,4,6-Trimethylphenyl)amino)carbonyl)-4-methyl-2-thiazolyl)carbamic acid, 1,1-dimethylethyl ester, used as enzyme inhibitors, for prohylaxis of inflammatory bowel disease; modulation of immunology
12/27/2005US6979692 Triamide-substituted heterobicyclic compounds
12/27/2005US6979691 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/27/2005US6979690 Oxo or oxy-pyridine compounds as 5-HT4 receptor modulators
12/27/2005US6979689 Antitussive, decongestant and diphenhydramine antihistamine; cough, congestion and allergy symptom relief
12/27/2005US6979688 Controlling hand foot syndrome, painful redness, skin cracking from 5-fluorouracil treatment; applying uracil ointment
12/27/2005US6979687 Theophylline-based soluble guanylyl cyclase activators KMUP-1 analogues enhanced cyclic GMP and K+ channel activities on rabbit corpus cavernosum smooth muscle and intercavernous pressure activities
12/27/2005US6979686 A piperidinyl-phenyl-pyridinyl-pyrazole derivatives; tumor necrosis factor mediated disorders, bone resorption, graft vs. host reaction, atherosclerosis, arthritis, rheumatoid arthritis, gout, psoriasis; chemical synthesis
12/27/2005US6979685 Drug mixture comprising 2-(4-Morpholinyl)-1-(2-naphthalenethoxy)cyclopentane; arrhythmia, diseases of central nervous system, convulsions, epileptic spasms, depression, anxiety, schizophrenia, Parkinson's disease, respiratory disorders
12/27/2005US6979684 useful as antitumor or anticancer agents
12/27/2005US6979683 Polymerase enzyme inhibitors
12/27/2005US6979682 Platelet-activating factor antagonist inhibition of angiogenesis and tumor growth induced by basic fibroblast
12/27/2005US6979681 Half-sandwich ruthenium (II) compounds comprising nitrogen containing ligands for treatment of cancer
12/27/2005US6979680 Glycosaminoglycans having an average molecular weight of 2400 D suitable for the treatment of senile dementia
12/27/2005US6979679 Bone disorders; antiinflammatory agents; antiarthritic agents; mixture of chondroitin sulfate, n-acetylglucosamine and hyaluronic acid
12/27/2005US6979677 Inhibition of vascular smooth muscle cell proliferation
12/27/2005US6979676 Pharmaceutical composition containing and indolopyrrolocarbazole derivative
12/27/2005US6979675 Treatment of cancer with 2-deoxyglucose
12/27/2005US6979586 Magnetic random access memory array with coupled soft adjacent magnetic layer
12/27/2005US6979539 Regulation of endogenous gene expression in cells using zinc finger proteins
12/27/2005US6979470 A curcuminoid species, e.g., curcumin, a diterpene lactone species, e.g., andrographolide, and a triterpene, e.g., ursolic acid or oleanolic acid; antiinflammatory agents; antiarthritic agents; side-effect reduction.
12/27/2005US6979468 Oral composition and method for the treatment of inflammatory cutaneous disorders
12/27/2005US6979463 Stable extended release oral dosage composition
12/27/2005US6979461 Method for producing liposome preparation
12/27/2005US6979459 Treatment of skin damage using polyenylphosphatidycholine
12/27/2005US6979458 high dosage form of a glucosamine and chondroitin nutraceutical mixture with vitamins B3, C and E, sodium hyaluronate and a solubilizer; fast absorbing, tasteless, odorless; non-steroidal antiinflammatory agents; vasodilator
12/27/2005US6979455 producing concentrate from a carrier having a modified ethylene polymer and optionally an olefin polymer, with one or more biocidal antimicrobial agents compounded therein; does not exhibit chalking and clumping of antimicrobial agent on surface
12/27/2005US6979454 Biologically active composition
12/27/2005US6979441 Method for topical treatment of carpal tunnel syndrome
12/27/2005US6979437 Drug delivering by inhaling or breathing to respiratory tract with a reduced drug dosage, comparing with traditional oral administration; dry powder drugs, emergency treatment
12/27/2005CA2356325C Topical compositions comprising protected functional thiols
12/27/2005CA2346961C Patient temperature regulation method and apparatus
12/27/2005CA2337509C Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method
12/27/2005CA2327187C Transdermal therapeutic system containing pergolide
12/27/2005CA2305463C Aminobutanoic acid derivatives
12/27/2005CA2290506C 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors
12/27/2005CA2280099C Medical aerosol formulations
12/27/2005CA2252050C Buccal, non-polar spray or capsule
12/27/2005CA2206799C Small molecule inhibitors of rotamase enzyme activity
12/27/2005CA2199194C Medicament for preventive and/or therapeutic treatment of hyperphosphatemia
12/27/2005CA2189271C Novel erythromycin derivatives, method for their preparation and their use as drugs
12/27/2005CA2188887C Nutritional coffee composition
12/27/2005CA2166001C Stable solid formulation of enalapril salt and process for preparation thereof
12/27/2005CA2160712C Novel 1,3-benzodioxole and 1,2-dialkoxybenzene derivatives as ocular hypotensive agents
12/27/2005CA2156287C Indolin-2-one derivative
12/27/2005CA2131911C Minimizing progestin associated breakthrough bleeding
12/27/2005CA2117257C Alginate-containing wound dressing
12/23/2005CA2495134A1 Phosphonate inhibitors of adenosine kinase
12/22/2005WO2005121368A1 Chimeric gapped oligomeric compositions
12/22/2005WO2005121348A1 Lipid encapsulated interfering rna
12/22/2005WO2005121327A2 Biosynthetic gene cluster for the production of a complex polyketide
12/22/2005WO2005121320A1 Autonomouos replication promoter for stem cells
12/22/2005WO2005121215A2 Polypeptides with the capacity to entrap drugs and release them in a controlled way
12/22/2005WO2005121161A1 Novel fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof
12/22/2005WO2005121160A2 11, 12 cyclic thiocarbamate macrolide antibacterial agents
12/22/2005WO2005121153A1 Condensed pyrimidine derivative and xanthine oxidase inhibitor
12/22/2005WO2005121151A2 Thienopyridinone compounds and methods of treatment
12/22/2005WO2005121149A1 Furanopyrimidine compounds effective as potassium channel inhibitors
12/22/2005WO2005121143A1 Flavopereirine derivatives for cancer therapy
12/22/2005WO2005121140A1 Pyrrolopyridine derivatives
12/22/2005WO2005121139A1 Substituted tricyclic benzimidazoles
12/22/2005WO2005121138A2 Heterotricyclic compounds for use as hcv inhibitors
12/22/2005WO2005121136A1 Salt of phosphoric acid with 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)-ethoxy] benzy] thiazolidin-2,4-dione and a method of its preparation
12/22/2005WO2005121135A1 Vla-4 inhibitor
12/22/2005WO2005121134A1 Thiophene derivatives, their manufacture and use as pharmaceutical agents
12/22/2005WO2005121132A1 Fused heterocyclic compound having anti-hcv effect
12/22/2005WO2005121131A1 Dpp-iv inhibitors
12/22/2005WO2005121130A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
12/22/2005WO2005121129A1 Novel propenone derivatives containing aromatic rings, a maufacturing process thereof and a composition containing the same using as an antiinflammatory agent
12/22/2005WO2005121126A1 Polycyclic pyrazines as potassium ion channel modulators
12/22/2005WO2005121124A1 Complexes of e-2-methoxy-n-(3-{4-[3-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide and methods of preparing same
12/22/2005WO2005121123A1 Compounds as cor5 antagonists
12/22/2005WO2005121122A1 Imidazol-2-one compounds useful in the treatment of various disorders
12/22/2005WO2005121120A1 Thiophene hydroxamic acid derivatives and their use as hdac inhibitors
12/22/2005WO2005121113A1 Novel tetracyclic tetrahydrofuran derivatives
12/22/2005WO2005121112A1 Medicinal compositions containing 6-hydroxybenz- bromarone or salts thereof
12/22/2005WO2005121107A1 Pyrazolo pyrimidines
12/22/2005WO2005121105A1 Novel 3-phenyltetrahydrocinnolin-5-ol derivative and medicinal use thereof
12/22/2005WO2005121103A1 Benzimidazoles, method for producing them and the use thereof as drugs
12/22/2005WO2005121100A1 Melanocortin-4 receptor binding compounds and methods of use thereof
12/22/2005WO2005121099A1 2h or 3h-benzo[e]indazol-1-yle carbamate derivatives, the preparation and therapeutic use thereof
12/22/2005WO2005121097A2 Pyrazole derivatives, compositions containing such compounds and methods of use
12/22/2005WO2005121095A1 Pyridine analogs as c5a antagonists
12/22/2005WO2005121094A1 Piperazine and piperidine derivatives as anti-hiv-agents
12/22/2005WO2005121091A1 Aroyl-o-piperidine derivatives for the treatment of diabetes-related problems
12/22/2005WO2005121089A1 Dpp-iv inhibitors
12/22/2005WO2005121088A1 New disubstituted phenylpiperidines as modulators of dopamine and serotonin neurotransmission
12/22/2005WO2005121087A1 New disubstituted phenylpiperidines/piperazines as modulators of dopamine neurotransmission
12/22/2005WO2005121085A1 Aza-bicyclo`3.1.0!hex-1-yl derivatives active as nk1 antagonists
12/22/2005WO2005121080A1 Histamine h3 receptor agents, preparation and therapeutic uses
1 ... 4422 4423 4424 4425 4426 4427 4428 4429 4430 4431 4432 4433 4434 4435 4436 4437 4438 4439 4440 4441 4442 ... 7860